CBIO Q3 2017 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$327M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$70,060

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$962,346

Balance Sheet

Total Assets

$116M

Total Liabilities

$7M

Stockholders' Equity

$109M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$18,500	-100.0%
Gross Profit	-$70,060	$18,500	-478.7%
Operating Income	-$8M	-$8M	-3.7%
Net Income	-$8M	-$8M	-1.2%